Real-time enrollment status for this leiomyosarcoma clinical trial
Current Status
Unknown
Checked: March 2, 2026 at 10:10 AM UTC
| NCT Number | NCT03420014 |
| Recruiting Status | Unknown |
| Condition | Leiomyosarcoma |
| Phase | Clinical Trial |
| Target Enrollment | 114 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Philogen S.p.A. |
| Last Updated on CT.gov | October 10, 2023 (Oct 10, 2023) |
As of March 2, 2026: Clinical trial NCT03420014 is currently unknown participants. This clinical trial study for leiomyosarcoma is not currently accepting new participants at 8 locations across the United States. The study is sponsored by Philogen S.p.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03420014 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03420014 was last updated Oct 10, 2023 (October 10, 2023). HelloStudys verifies this status automatically.